Back to search

United Kingdom· GB-APID-15116311000001105

Vinorelbine 10mg/1ml concentrate for solution for infusion vials

A vinorelbine product containing vinorelbine, registered in United Kingdom by Accord-UK Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC L01CA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVinorelbine 10mg/1ml concentrate for …ATCL01CA04REGISTER NO.GB-APID-1511631100000…PACKS LISTED4CHECKEDSeptember 13, 2026

Where it is registered

Vinorelbine is registered in 18 of 19 countries.

Countries holding a registration under ATC L01CA04 (vinorelbine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Vinorelbine · ATC L01CA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinorelbine costs, country by country.

Normalised to the WHO defined daily dose (18 mg), the median price runs from $23.93 in France to $49.84 in Switzerland — a ×2.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vinorelbine · price per daily dose (18 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$49.84
  • IT Italy$38.71
  • FR France$23.93
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Vinorelbine
Manufacturer
Accord-UK Ltd
Country
United Kingdom (GB)
ATC code
L01CA04
ATC class
Vinorelbine
Defined daily dose
18 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 4

  • gtin
    5012617017765
  • gtin
    05012617017765
  • gtin
    5055565733639
  • gtin
    05055565733639

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

536 interactions on record for vinorelbine.

Graded by severity as the source publishes them — 60 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vinorelbine · interactions on record

536 records

  • 60 severe
  • 307 moderate
  • 17 minor
  • 152 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinorelbine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinorelbine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Eberelbin, Navelbine
  • Belgium · Vinorelbin Eugia, Vinorelbine Accord Healthcare
  • Bulgaria · Винорелбин "ебеве"
  • Cyprus · Navirel, Vinorelbine Accord
  • Czechia · Navelbine, Navelbine Oral
  • Germany · Bendarelbin, Navelbine
  • Denmark · Navelbine, Navirel
  • Estonia · Navelbine, Vinorelbin Ebewe
  • Spain · Navelbine, Vinorelbina Accord
  • Finland · Navelbine, Vinorelbin Ebewe
  • France · Navelbine, Vinorelbine
  • Greece · Navelbine, Zaolin
  • Croatia · Vinorelsin
  • Hungary · Vinorelbin Sandoz
  • Ireland · Navelbine, Vinorelbine Accord
  • Iceland · Navelbine, Navirel
  • Italy · Navelbine, Vinorelbina Accord
  • Lithuania · Navelbine, Vinorelbin Ebewe
  • Luxembourg · Vinorelbin Ab, Vinorelbin Eugia
  • Latvia · Vinorelbine Accord
  • Malta · Vinorelbine Lotus, Vinorelbine Medac
  • Netherlands · Navelbine, Navirel
  • Norway · Navelbine, Navirel
  • Poland · Navelbine, Navirel
  • Portugal · Navelbine, Vinorrelbina
  • Romania · Navelbine, Vinorelbin Teva
  • Sweden · Navelbine, Navirel
  • Slovenia · Vinorelbin Accord, Vinorelbin Sandoz
  • Slovakia · Navelbine, Navelbine Oral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fccc6fa1-d674-4d5c-a093-34a1e63055d9
GET /v1/drugs/fccc6fa1-d674-4d5c-a093-34a1e63055d9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "15116311000001105",
  "desc": "Vinorelbine 10mg/1ml concentrate for solution for infusion vials (Accord-UK Ltd)",
  "form": "Solution for infusion",
  "vpid": "36150411000001106",
  "source": "dmd",
  "vtm_id": "777938003",
  "strength": "10 mg",
  "substance": "Vinorelbine",
  "ingredient": "Vinorelbine tartrate",
  "supplier_code": "18471011000001103"
}

See everything about vinorelbine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.